PC
DMAA

Periscope Capital’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

Periscope Capital’s Portfolio DMAA Stock Details DMAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Hold
50,000
– – 0.06% 218
2025
Q4 		$519K Hold
50,000
– – 0.06% 180
2025
Q3 		$514K Buy
+50,000
New +$513K 0.08% 140

Other funds holding DMAA

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Periscope Capital's DMAA Position: Q1 2026 in Review

Periscope Capital held its Drugs Made In America Acquisition Corp (DMAA) position steady in Q1 2026 at 50,000 shares worth $525K. The position accounts for 0.06% of the portfolio, ranked #218.

Periscope Capital first reported a position in DMAA in Q3 2025 and has held it in 3 quarters since. 39 funds tracked by Wall St. Rank hold DMAA as of Q1 2026.

  • Periscope Capital held 50,000 shares of Drugs Made In America Acquisition Corp worth $525K as of Q1 2026.
  • Periscope Capital left its Drugs Made In America Acquisition Corp share count unchanged in Q1 2026.
  • Drugs Made In America Acquisition Corp made up 0.06% of Periscope Capital's portfolio in Q1 2026, its #218 holding.
  • Periscope Capital first reported a position in Drugs Made In America Acquisition Corp in Q3 2025 and has held it in 3 quarters since.
  • 39 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.